The Claim
Growth hormone increases glycerol release by approximately 20% in cultured human adipocytes and reduces insulin-stimulated Akt phosphorylation at Ser473 in the same cells.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Growth hormone increases glycerol release by about 20% in human fat cells grown in a lab and decreases the activation of Akt at Ser473 in response to insulin in those same cells.
See the scientific wording
Growth hormone increases glycerol release by approximately 20% in cultured human adipocytes, indicating enhanced lipolysis, and reduces insulin-stimulated Akt phosphorylation at Ser473, suggesting impaired insulin signaling.
Growth hormone triggers a chain reaction in fat cells that breaks down stored fat and blocks insulin's ability to signal properly. It turns off a protein that normally keeps fat from breaking down, which releases more glycerol. At the same time, it disables a key switch that insulin uses to tell the cell to store fat, making the cell resistant to insulin.
What the research says
1 studyStudy: Growth hormone acts along the PPARγ-FSP27 axis to stimulate lipolysis in human adipocytes.
Growth hormone makes fat cells break down fat more and become less responsive to insulin, and this study shows how it does that by messing with a key protein (PPARγ) that controls fat storage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.